ARTICLE | Company News
Proteonomix, Cohen McNiece Foundation Inc. deal
March 21, 2011 7:00 AM UTC
The not-for-profit foundation granted Proteonomix exclusive, worldwide rights to its UMK-121 technology covering the mobilization of bone marrow stem cells. Proteonomix plans to sublicense the techno...